Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...
A Pensacola man was sentenced to 10 years in federal prison for drug distribution charges. Jermaine Z. Lewis, 32, received his decade-long sentence for conspiracy to distribute and possession with ...
Lilly's Next-Gen Drug Shows Greater Weight Loss Than Zepbound in Late-Stage Trial By Christy Santhosh and Sriparna Roy Dec 11 (Reuters) - Eli Lilly said on Thursday its next-generation obesity drug ...
Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...
Dec 11 (Reuters) - Rezolute (RZLT.O), opens new tab said on Thursday its therapy aimed at controlling excessive insulin activity in patients with a rare genetic disorder did not show significant ...
Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned approval application. The company had been evaluating ersodetug as a treatment ...
OMAHA, Neb. (WOWT) - Drug cartels are producing a cheaper form of a lethal drug and DEA officials here in the metro say the stuff has made its way to our neighborhoods. Powdered fentanyl is nothing ...
Briton Dalton Smith's world-title challenge against WBC light-welterweight champion Subriel Matias remains on, despite the champion returning adverse drug-test findings. The Puerto Rican tested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback